Intercept to Present at Upcoming Conferences
September 01 2017 - 4:05PM
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases, today
announced management will be participating in the following
investor conferences:
- Baird 2017 Global Healthcare Conference on September 6, 2017 at
1:25 p.m. Eastern Time
- Morgan Stanley 15th Annual Global Healthcare Conference on
September 12, 2017 at 11:45 a.m. Eastern Time
Webcast information for these events will be available on the
Investors page of Intercept's website at
http://ir.interceptpharma.com. Archived webcasts will be available
on Intercept's website for approximately two weeks.
About InterceptIntercept is a biopharmaceutical
company focused on the development and commercialization of novel
therapeutics to treat progressive non-viral liver diseases,
including primary biliary cholangitis (PBC), nonalcoholic
steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and
biliary atresia. Founded in 2002 in New York, Intercept now has
operations in the United States, Europe and Canada.
CONTACT:
For more information about Intercept Pharmaceuticals, please contact:
Intercept Pharmaceuticals:
Mark Vignola
+1-646-747-1000
investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Investor inquiries: investors@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Sep 2023 to Sep 2024